Guttate Psoriasis clinical trials at UCSF

1 research study open to eligible people

Guttate psoriasis causes red, scaly spots on the skin. UCSF is running a study to see how well the drug guselkumab works for people with this condition. The trial also looks at the genetic factors that affect treatment response.

Showing trials for

  • Guselkumab Immunogenetics

    open to eligible people ages 18 years and up

    This is a two-arm open-label study to evaluate the clinical and immunogenetic responses of patients with plaque or guttate psoriasis to treatment with guselkumab.

    San Francisco, California

Our lead scientists for Guttate Psoriasis research studies include .

Last updated: